Protective Activities of Growth Hormone-Releasing Hormone Antagonists against Toxin-Induced Endothelial Injury [PDF]
EndocrinesGHRH regulates the secretion of GH from the anterior pituitary gland, previously associated with cancer progression and inflammation. An emerging body of evidence suggests that GHRHAnt support endothelial barrier function, but the mechanisms mediating ...
Saikat Fakir, Nektarios Barabutis
doaj +2 more sources
Gonadotropin-Releasing Hormone Antagonists-A New Hope in Endometriosis Treatment? [PDF]
J Clin Med, 2023 Rzewuska AM +7 more
europepmc +3 more sources
Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis. [PDF]
Arch Gynecol Obstet, 2023 Xin L, Ma Y, Ye M, Chen L, Liu F, Hou Q.
europepmc +3 more sources
Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research. [PDF]
J Clin Med ResWang JY, Zhang Y, Ding J.
europepmc +3 more sources
Draft Genome Sequence of Streptomyces silvensis ATCC 53525, a Producer of Novel Hormone Antagonists. [PDF]
Genome Announc, 2016 Johnston CW, Li Y, Magarvey NA.
europepmc +3 more sources
Neural Regeneration Research, 2022 Both inflammation and anti-inflammation are involved in the protection of retinal cells. Antagonists of the hypothalamic growth hormone-releasing hormone receptor (GHRHR) have been shown to possess potent anti-inflammatory properties in experimental ...
Ling-Ping Cen +3 more
doaj +1 more source
Differential Changes in Expression of Stress- and Metabolic-related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal [PDF]
, 2013 Chronic morphine treatment and naloxone precipitated morphine withdrawal activates stress-related brain circuit and results in significant changes in food intake, body weight gain and energy metabolism.
Ferenczi, Szilamér +6 more
core +13 more sources
Androgen deprivation therapy and side effects: are GnRH antagonists safer?
Asian Journal of Andrology, 2021 Androgen deprivation therapy (ADT) with gonadotropin-releasing hormone (GnRH) agonists and antagonists is the mainstay of advanced prostate cancer treatment. Both drug classes decrease levels of luteinizing hormone and follicle-stimulating hormones (FSH),
Stephen J Freedland +1 more
doaj +1 more source
Impact of Androgen Deprivation Therapy on Cardiovascular Outcomes in Prostate Cancer
Société Internationale d’Urologie Journal, 2022 PurposeSubstantial evidence indicates that men with prostate cancer are at an increased risk for cardiovascular disease, and medical and surgical androgen deprivation therapy is associated with further increased cardiovascular risk. There are conflicting
Laurence Klotz +3 more
doaj +1 more source
F&S Reports, 2023 Gonadotropin-releasing hormone (GnRH) is central to the control of the entire hypothalamic-pituitary-gonadal axis. Manipulation of GnRH, in turn, regulates pituitary response and ovarian hormone production.
Farrah L. Saleh, M.D. +1 more
doaj +1 more source